pyrrolidine dithiocarbamate has been researched along with Coronary Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Coronary Disease
Article | Year |
---|---|
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis | 2000 |